Indeed, a proof of protective effects of c-Maf deletion not only in type 1 but also in type 2 diabetes using the mouse model can strengthen the notion of a close interaction between c-Maf and Sglt2. Here, SLC5A2 is linked to type 2 diabetes mellitus.